↓ Skip to main content

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

Overview of attention for article published in Journal of Hematology & Oncology, September 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
Published in
Journal of Hematology & Oncology, September 2021
DOI 10.1186/s13045-021-01158-3
Pubmed ID
Authors

Ivan Bièche, Florence Coussy, Rania El-Botty, Sophie Vacher, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Cécile Reyes, David Gentien, Fabien Reyal, Francesco Ricci, André Nicolas, Caterina Marchio, Anne Vincent-Salomon, Marick Laé, Elisabetta Marangoni

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 13%
Student > Master 2 13%
Student > Bachelor 1 7%
Other 1 7%
Student > Postgraduate 1 7%
Other 0 0%
Unknown 8 53%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 13%
Unspecified 1 7%
Agricultural and Biological Sciences 1 7%
Sports and Recreations 1 7%
Chemistry 1 7%
Other 0 0%
Unknown 9 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 September 2021.
All research outputs
#14,555,398
of 23,310,485 outputs
Outputs from Journal of Hematology & Oncology
#698
of 1,208 outputs
Outputs of similar age
#214,467
of 429,909 outputs
Outputs of similar age from Journal of Hematology & Oncology
#33
of 49 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,208 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,909 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.